Kornitzer Capital Management’s Impax Laboratories, Inc. IPXL Stock Holding History

Kornitzer Capital Management’s Portfolio IPXL Stock Details IPXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-443,691	Closed	-$12.8M	–	469
2016 Q2	$12.8M	Sell	443,691 -25,559	-5%	-$833K	0.23%	142
2016 Q1	$15M	Sell	469,250 -141,690	-23%	-$4.98M	0.26%	139
2015 Q4	$26.1M	Sell	610,940 -152,820	-20%	-$6.1M	0.43%	80
2015 Q3	$26.9M	Sell	763,760 -67,980	-8%	-$3.06M	0.43%	81
2015 Q2	$38.2M	Sell	831,740 -224,940	-21%	-$10.7M	0.52%	66
2015 Q1	$49.5M	Buy	1,056,680 +280,980	+36%	+$11.2M	0.6%	55
2014 Q4	$24.6M	Buy	+775,700	New	+$22.7M	0.29%	109

Other funds holding IPXL

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Hound Partners New York $799M AUM 9.54% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Kornitzer Capital Management's IPXL Position: Q3 2016 in Review

Kornitzer Capital Management sold out of Impax Laboratories, Inc. (IPXL) in Q3 2016, closing a stake of 443,691 shares — an estimated $12.8M sold.

Kornitzer Capital Management first reported a position in IPXL in Q4 2014 and held it in 7 quarters. The position peaked at $49.5M in Q1 2015. 196 funds tracked by Wall St. Rank hold IPXL as of Q3 2016.

Kornitzer Capital Management reported no remaining Impax Laboratories, Inc. position as of Q3 2016 after selling out during the quarter.
Kornitzer Capital Management sold 443,691 Impax Laboratories, Inc. shares in Q3 2016, an estimated $12.8M.
Kornitzer Capital Management first reported a position in Impax Laboratories, Inc. in Q4 2014 and held it in 7 quarters.
Kornitzer Capital Management's Impax Laboratories, Inc. position peaked at $49.5M in Q1 2015.
196 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q3 2016.

Based on Kornitzer Capital Management's 13F filing for Q3 2016, filed 31 Oct 2016.